SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001213900-19-018487
Filing Date
2019-09-20
Accepted
2019-09-20 10:04:51
Documents
4
Effectiveness Date
2019-09-20

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT defc14a091919_amag.htm DEFC14A 2945029
2 GRAPHIC amag_logo.jpg GRAPHIC 42149
3 GRAPHIC chart_001.jpg GRAPHIC 162821
4 GRAPHIC chart_002.jpg GRAPHIC 164058
  Complete submission text file 0001213900-19-018487.txt   3454120
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filed by) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 001-10865 | Film No.: 191102799
SIC: 2834 Pharmaceutical Preparations